18F-DCFPyL靶向PSMA PET显像中半定量参数:正常器官摄取变异性
分析了64例有前列腺癌病史患者的65次连续18F-DCFPyL PET/CT扫描,测量泪腺、唾液腺、肝、脾及双肾的SUVmean和SULmean变异性。肝脏COV最低(SUVmean 13.8%,SULmean 14.5%),低于其他器官且低于报道的18F-FDG肝脏变异性。SUVmean的变异性略小于SULmean,作者认为SUVmean可能是18F-DCFPyL图像定量的更优参数。
要点
- 肝脏摄取变异性最低,SUVmean COV 13.8%,SULmean COV 14.5%,均低于其他18F-DCFPyL高摄取器官。
- 肝脏变异性低于文献报道的18F-FDG肝脏变异性。
- SUVmean变异性略小于SULmean,作者认为SUVmean可能是更优定量参数。
核心结论
- 18F-DCFPyL在正常肝脏的摄取变异性小于其他18F-DCFPyL高摄取器官,且小于报道的18F-FDG肝脏变异性。
- SUVmean的变异性略小于SULmean,提示SUVmean可能是18F-DCFPyL图像定量的更优参数。
研究设计与样本
- 分析了64例有前列腺癌病史患者的65次连续18F-DCFPyL PET/CT扫描。
- 对泪腺、主要唾液腺、肝、脾及双肾勾画感兴趣体积,计算以体重或瘦体重归一化的平均SUV(SUVmean或SULmean)。
- 计算所有扫描中各器官的平均SUV、标准差及变异系数(COV),并对肝右叶中心3 cm球体进行相同分析。
主要发现
- 右泪腺SUVmean 6.6±1.8,左泪腺6.4±1.8。
- 右腮腺SUVmean 9.1±2.0,左腮腺9.0±2.1;右颌下腺9.6±2.3,左颌下腺9.4±2.2。
- 全肝SUVmean 5.0±0.7,肝内3 cm球体5.1±0.7,脾4.0±1.5。
- 右肾SUVmean 20.1±4.6,左肾19.4±4.5。
- SULmean总体较低但趋势相似;SUVmean与SULmean的COV在肝脏最低(分别为13.8%和14.5%),低于其他任何器官且低于18F-FDG PET的相应COV。
关键数值与推荐
- 肝脏SUVmean的COV为13.8%,SULmean的COV为14.5%,低于其他器官及18F-FDG PET的相应COV。
- 肝内3 cm球体SUVmean的COV为14.2%,SULmean的COV为14.7%,与全肝变异性相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
18F-DCFPyL is a small-molecule inhibitor of the prostate-specific membrane antigen that has shown promise for evaluation of primary and metastatic prostate cancer using PET. Measuring the variability in normal-organ uptake of 18F-DCFPyL is necessary to understand its biodistribution, aid image interpretation, judge the reliability of scan quantification, and provide a basis for therapeutic monitoring. Methods: Sixty-five consecutive 18F-DCFPyL PET/CT scans from 64 patients with a history of prostate cancer were analyzed. Volumes of interest were defined for the lacrimal glands, major salivary glands, liver, spleen, and both kidneys. The mean SUV normalized to body mass or to lean body mass (SUL) was calculated for each volume of interest. The average SUV across all scans, the SD, and the coefficient of variation (COV) for each organ were calculated. The same parameters were also derived for a 3-cm sphere drawn in the center of the right lobe of the liver. Results: The average SUVmean for all selected organs measured was 6.6 ± 1.8 for the right lacrimal gland, 6.4 ± 1.8 for the left lacrimal gland, 9.1 ± 2.0 for the right parotid gland, 9.0 ± 2.1 for the left parotid gland, 9.6 ± 2.3 for the right submandibular gland, 9.4 ± 2.2 for the left submandibular gland, 5.0 ± 0.7 for the whole liver, 5.1 ± 0.7 for a 3-cm sphere in the liver, 4.0 ± 1.5 for the spleen, 20.1 ± 4.6 for the right kidney, and 19.4 ± 4.5 for the left kidney. SULmean was lower overall, although demonstrating similar trends. The COV of SUVmean and SULmean was lower in the liver (13.8% and 14.5%, respectively) than in any other organ and was less than the comparable COV for 18F-FDG PET. The COV of SUVmean and SULmean in the 3-cm sphere in the liver was also low and similar to the variability in the whole liver (14.2% and 14.7%, respectively). Conclusion:18F-DCFPyL uptake in normal liver demonstrates less variability than in other 18F-DCFPyL-avid organs, and its variability is less than the reported variability of 18F-FDG in liver. Variability was slightly less for SUVmean than for SULmean, suggesting that SUVmean may be the preferable parameter for quantification of images obtained with 18F-DCFPyL.
引用
- Li X, Rowe SP, Leal JP, et al. Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake. J Nucl Med. 2016. PMID: 27932557. doi:10.2967/jnumed.116.179739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。